Effects of consumption of the test food on bone density in healthy Japanese menopause wome

Not Applicable

• Conditions: Healthy Japanese subjects

• Registration Number: JPRN-UMIN000046570
• Lead Sponsor: ORTHOMEDICO Inc.

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2022-10-02
• Study Start: 2023-09-30
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: Female
• Target Recruitment: 36

Inclusion Criteria

Not provided

Exclusion Criteria

1. Subjects who are osteoporosis (YAM score of total amount of lumbar vertebra is less than 70%) 2. Subjects who have taken medications for osteoporosis 3. Subjects who are undergoing medical treatment or have a medical history of malignant tumor, heart failure, and myocardial infarction 4. Subjects who have a pacemaker or an implantable cardioverter defibrillator (ICD) 5. Subjects currently undergoing treatment for any of the following chronic disease: cardiac arrhythmia, liver disorder, kidney disorder, cerebrovascular disorder, rheumatism, diabetes mellitus, dyslipidemia, hypertension, or any other chronic diseases 6. Subjects who receive hormonal therapy 7. Subjects who take "Foods for Specified Health Uses", "Foods with Functional Claims", or other functional food/beverage in daily use 8. Subjects who take supplements, "Foods for Specified Health Uses", "Foods with Functional Claims", or "Food with Nutrient Function Claims" which may influence bone metabolism such as calcium, vitamin D or K, magnesium, lactic acid bacteria, or isoflavones (including daidzein, genistein, or equol) in daily use 9. Subjects currently taking medicines (include herbal medicines) and supplements 10. Subjects who are allergic to medications and/or the test-food-related products 11. Subjects who suffer from COVID-19 12. Subjects who have been enrolled in other clinical trials within the last 28 days before the agreement to participate in this trial or plan to participate another trial during this trial 13. Subjects who are judged as ineligible to participate in the study by the physician

Study & Design

• Study Type: Interventional
• Study Design: Not specified